Gastrointestinal stromal tumors (GIST) related emergencies

被引:108
|
作者
Sorour, Magdy A. [1 ]
Kassem, Mohamed I. [1 ]
Ghazal, Abd El-Hamid A. [1 ]
El-Riwini, Mohamed T. [1 ]
Abu Nasr, Adel [1 ]
机构
[1] Univ Alexandria, Fac Med, Dept Surg, Alexandria, Egypt
关键词
Gastrointestinal stromal tumors (GIST); CD117; Imatinib; PROGNOSTIC-FACTORS; SURGICAL-MANAGEMENT; DIAGNOSIS; FEATURES; HEMOPERITONEUM; PERFORATION; EXPERIENCE; RUPTURE; ERA;
D O I
10.1016/j.ijsu.2014.02.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, accounting for 1-3% of all gastrointestinal malignancies. Throughout the whole length of the gastrointestinal tract, GIST arises most commonly from the stomach followed by small bowel. The clinical presentations of GIST are highly variable according to their site and size. The most frequent symptoms are anemia, weight loss, gastrointestinal bleeding, abdominal pain and massrelated symptoms. Patients may present with acute abdomen, obstruction, perforation or rupture and peritonitis. Surgical resection is the "gold standard" for therapy of GIST. Recently, targeted therapy with inhibitors of tyrosine kinase receptors (imatinib) has been introduced for the management of advanced and metastatic tumors. Purpose: The aim of this work is to present the experience of the Gastrointestinal Surgery Unit, Alexandria Faculty of Medicine in the management of patients with GIST related emergencies. Patients and methods: This study was carried out on all patients with gastrointestinal stromal tumors who presented to the Gastrointestinal Surgery Unit, Main Alexandria University Hospital in an emergency situation during the period from January 2005 till December 2012. All patients' data, clinical presentations, radiological and endoscopic data, surgical procedures, complications, and survival data were collected, reviewed and analyzed. After approval of local ethics committee, all patients included in the study were informed well about the procedure and an informed written consent was obtained from every patient before carrying the procedure. Results: Between January 2005 and December 2012; 92 patients (54 males and 38 females) were admitted with different emergency presentations of clinically and radiologically suspected GISTs. The tumors were located in the stomach in 49 patients, in the duodenum in 6 patients, in the small intestine in 27 patients, in the small intestinal mesentery in 4 patients, in the colon in 3 patients and in the rectum in 3 patients. The most frequent presenting symptom was gastrointestinal bleeding in 45 patients. Twenty-six patients presented with intestinal obstruction, 14 patients with intraperitoneal hemorrhage and 7 patients with rupture and peritonitis. Ninety patients were operated upon. Two patients presented with extensive GIST, and were not candidate for surgical treatment. All operated patients underwent surgical resection. Complete macroscopic resection was achieved in 86 patients (95.6%), while 4 patients (4.4%) had incomplete resection. All over 11 patients developed metastases, or recurrence. The 3 and 5-years overall survival rates for all patients, using the Kaplan-Meier actuarial curve, were 92.1% and 81.4% respectively. The 3 and 5-years disease-free survival rates for all patients were 73.2% and 64.5% respectively. Conclusion: Although GISTs are uncommon, their incidence is probably increasing especially their emergency presentations. The emergency surgeon must be acquainted with the disease, its emergency presentation and principles of surgery in the presence of GIST tumors. Early diagnosis and treatment would save life of many patients who presented with GIST related emergencies. Surgery is still the gold standard treatment in localized GIST, although the percentage of relapse is not low even after radical surgery. The prognosis is strictly related to size and completeness of surgical resection. We strongly advocate that all patients with a GIST be carefully and regularly followed-up for an indefinite period. The large number of patients in this series is an alarming signal for further studies to elucidate the pathogenesis of this disease. (C) 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:269 / 280
页数:12
相关论文
共 50 条
  • [41] Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies
    Emile, Jean-Francois
    M S-MEDECINE SCIENCES, 2013, 29 (6-7): : 630 - 636
  • [42] Gastrointestinal stromal tumors (GIST): New treatment expectations
    Bodega Quiroga, Ignacio
    Tejedor Togores, Patricia
    Saez Garcia, Miguel Angel
    Peraza Casajus, Jesus Manuel
    Rosado Dawid, Natalia
    Serrano Munoz, Angel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (08) : 506 - 507
  • [43] Pathology and molecular biology of gastrointestinal stromal tumors (GIST)
    Schildhaus, H. -U.
    Merkelbach-Bruse, S.
    Buettner, R.
    Wardelmann, E.
    RADIOLOGE, 2009, 49 (12): : 1104 - 1108
  • [44] Management of liver metastases of gastrointestinal stromal tumors (GIST)
    Vassos, Nikolaos
    Againny, Abbas
    Hohenberger, Werner
    Croner, Roland S.
    ANNALS OF HEPATOLOGY, 2015, 14 (04) : 531 - 539
  • [45] Immune microenvironment profiling of gastrointestinal stromal tumors (GIST).
    Pantaleo, Maria A.
    Indio, Valentina
    Tarantino, Giuseppe
    Agostinelli, Claudio
    Urbini, Milena
    Nannini, Margherita
    Saponara, Maristella
    Castelli, Chiara
    Stacchiotti, Silvia
    Gatto, Lidia
    Santini, Donatella
    De Leo, Antonio
    Pession, Andrea
    Astolfi, Annalisa
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Surgical Therapy for Gastrointestinal Stromal Tumors (GIST) of the Duodenum
    Hoeppner, Jens
    Marjanovic, Goran
    Kulemann, Birte
    Makowiec, Frank
    Hopt, Ulrich T.
    GASTROENTEROLOGY, 2012, 142 (05) : S1101 - S1101
  • [47] Gastrointestinal stromal tumors (GIST): Sonographic and endosonographic findings
    Dirks, K.
    Lutz, H.
    Ultrasound in Medicine and Biology, 2000, 26 (SUPPL. 2):
  • [48] The diagnostic value of immunohistochemistry in gastrointestinal stromal tumors (GIST)
    Radulescu, D.
    Stolnicu, S.
    Ungureanu, L.
    Jalba, L.
    Dumitriu, S.
    HISTOPATHOLOGY, 2008, 53 : 157 - 158
  • [49] Infrequent Tumors of the Gastrointestinal Tract Including Gastrointestinal Stromal Tumor (GIST)
    Ertuk, Mehmet
    Van den Abbeele, Annick D.
    PET CLINICS, 2008, 3 (02) : 207 - +
  • [50] Chemokines and chemokine signaling pathways as gastrointestinal stromal tumors (GIST)
    Cameron, S.
    Kitz, J.
    Fuezesi, L.
    Ramadori, G.
    ONKOLOGIE, 2010, 33 : 183 - 183